X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   TEVA PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
TEVA PHARMA
Dec-13
CADILA HEALTHCARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4542,678-   
Low Rs3052,326-   
Sales per share (Unadj.) Rs96.11,537.0-  
Earnings per share (Unadj.) Rs14.996.0-  
Cash flow per share (Unadj.) Rs17.8220.2-  
Dividends per share (Unadj.) Rs3.2084.05-  
Dividend yield (eoy) %0.83.4 25.1%  
Book value per share (Unadj.) Rs52.31,707.3-  
Shares outstanding (eoy) m1,023.74848.00-   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.91.6 242.5%   
Avg P/E ratio x25.526.1 97.9%  
P/CF ratio (eoy) x21.311.4 187.4%  
Price / Book Value ratio x7.31.5 495.2%  
Dividend payout %21.587.5 24.6%   
Avg Mkt Cap Rs m388,4582,121,900 18.3%   
No. of employees `00015.444.9 34.4%   
Total wages/salary Rs m13,3170-   
Avg. sales/employee Rs Th6,371.128,998.7 22.0%   
Avg. wages/employee Rs Th862.40-   
Avg. net profit/employee Rs Th986.11,811.5 54.4%   
INCOME DATA
Net Sales Rs m98,3761,303,346 7.5%  
Other income Rs m9410-   
Total revenues Rs m99,3171,303,346 7.6%   
Gross profit Rs m23,829356,922 6.7%  
Depreciation Rs m3,022105,351 2.9%   
Interest Rs m48625,600 1.9%   
Profit before tax Rs m21,262225,972 9.4%   
Minority Interest Rs m-3001,027 -29.2%   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-25-148,338 0.0%   
Tax Rs m5,716-2,759 -207.2%   
Profit after tax Rs m15,22681,419 18.7%  
Gross profit margin %24.227.4 88.5%  
Effective tax rate %26.9-1.2 -2,202.0%   
Net profit margin %15.56.2 247.8%  
BALANCE SHEET DATA
Current assets Rs m44,376880,275 5.0%   
Current liabilities Rs m34,071767,674 4.4%   
Net working cap to sales %10.58.6 121.2%  
Current ratio x1.31.1 113.6%  
Inventory Days Days5491 59.3%  
Debtors Days Days6296 65.0%  
Net fixed assets Rs m47,896425,702 11.3%   
Share capital Rs m1,0243,208 31.9%   
"Free" reserves Rs m48,7460-   
Net worth Rs m53,5191,447,770 3.7%   
Long term debt Rs m8,964666,430 1.3%   
Total assets Rs m100,1632,978,564 3.4%  
Interest coverage x44.79.8 455.4%   
Debt to equity ratio x0.20.5 36.4%  
Sales to assets ratio x1.00.4 224.5%   
Return on assets %15.73.6 436.6%  
Return on equity %28.45.6 505.9%  
Return on capital %34.34.9 695.4%  
Exports to sales %45.30-   
Imports to sales %5.90-   
Net fx Rs m35,8120-   
CASH FLOW
From Operations Rs m19,938207,686 9.6%  
From Investments Rs m-9,039-73,592 12.3%  
From Financial Activity Rs m-9,527-249,133 3.8%  
Net Cashflow Rs m1,372-115,039 -1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.16 Rs / USD

Compare CADILA HEALTHCARE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare CADILA HEALTHCARE With: MERCK LTD  ALEMBIC PHARMA  VENUS REMEDIES  DISHMAN PHARMA  IPCA LABS  



Today's Market

Sensex Trades Marginally Lower; IT Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the IT sector and power sector witnessing maximum selling pressure.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 21, 2017 12:08 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - STERLING BIOTECH COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS